Fig. 2.
Disease specific survival after recurrence
Kaplan-Meier estimates of disease specific survival after recurrence regarding (A) histological type, demonstrating a significantly better outcome in patients with type I endometrial cancer (p = 0.013) and (B) progesterone receptor expression, demonstrating a significantly better outcome in patients with positive receptor expression (p < 0.001).